Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
出版年份 2023 全文链接
标题
Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
作者
关键词
-
出版物
Current Cardiology Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-24
DOI
10.1007/s11886-023-01961-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
- (2023) Connie W. Tsao et al. CIRCULATION
- The role of obesity-related cardiovascular remodelling in mediating incident cardiovascular outcomes: a population-based observational study
- (2023) Liliana Szabo et al. European Heart Journal-Cardiovascular Imaging
- Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial
- (2023) Hertzel C. Gerstein et al. CIRCULATION
- Longitudinal Hemodynamic Correlates of and Sex Differences in the Evolution of Blood Pressure Across the Adult Lifespan: The Framingham Heart Study
- (2023) Gary F. Mitchell et al. Journal of the American Heart Association
- Body Composition and Risk of Incident Heart Failure in 1 Million Adults: A Systematic Review and Dose–Response Meta‐Analysis of Prospective Cohort Studies
- (2023) Ayodipupo S. Oguntade et al. Journal of the American Heart Association
- Sex‐Specific Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism in a Population‐Based Historical Cohort Study of Middle‐Aged and Older Individuals
- (2023) Annie Brink et al. Journal of the American Heart Association
- Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
- (2023) Utibe R. Essien et al. JAMA Network Open
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
- (2023) Salim S. Virani et al. CIRCULATION
- The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study
- (2023) Tobias Frischmuth et al. THROMBOSIS AND HAEMOSTASIS
- Sodium‐Glucose Cotransporter‐2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta‐Analysis of Randomized Trials and Systematic Review
- (2023) Hammad Rahman et al. Journal of the American Heart Association
- Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
- (2022) Joshua J. Joseph et al. CIRCULATION
- Trajectories of Blood Pressure in Midlife Women: Does Menopause Matter?
- (2022) Saad Samargandy et al. CIRCULATION RESEARCH
- Heart Failure Subtypes and Cardiomyopathies in Women
- (2022) Ersilia M. DeFilippis et al. CIRCULATION RESEARCH
- Arterial Stiffness and Long-Term Risk of Health Outcomes: The FHS
- (2022) Ramachandran S. Vasan et al. HYPERTENSION
- Social determinants of health and obesity: Findings from a national study of US adults
- (2022) Zulqarnain Javed et al. Obesity
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- (2022) Paul A. Heidenreich et al. CIRCULATION
- Effect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis
- (2022) Dae Yong Park et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on
- (2022) Chrysoula Boutari et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association between maternal adiposity measures and adverse maternal outcomes of pregnancy: Systematic review and meta‐analysis
- (2022) Nicola Heslehurst et al. Obesity Reviews
- National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020
- (2022) Rishav Adhikari et al. Journal of the American Heart Association
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
- (2022) Muthiah Vaduganathan et al. LANCET
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- (2022) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease
- (2022) Nicole L. Wolter et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
- (2022) Nikolaus Marx et al. CIRCULATION
- Obesity Management in Women of Reproductive Age
- (2021) S. Michelle Ogunwole et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
- (2021) Thomas A. Wadden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Trials
- (2021) Yao Hao Teo et al. Journal of the American Heart Association
- Sex Differences in Heart Failure With Preserved Ejection Fraction
- (2021) Yohei Sotomi et al. Journal of the American Heart Association
- Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association
- (2021) Nisha I. Parikh et al. CIRCULATION
- Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease:
- (2021) Aristithes G. Doumouras et al. CIRCULATION
- Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2021) Tiffany M. Powell-Wiley et al. CIRCULATION
- Metabolically Healthy/Unhealthy Overweight/Obesity Associations With Incident Heart Failure in Postmenopausal Women
- (2021) Amber R. Cordola Hsu et al. Circulation-Heart Failure
- Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis
- (2021) Dipender Gill et al. INTERNATIONAL JOURNAL OF OBESITY
- Adipose tissue estrogen production and metabolism in premenopausal women
- (2021) Natalia Hetemäki et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
- (2021) Birgit Vogel et al. LANCET
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined
- (2021) Julie R. Lundgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sex Differences in the Associations of Visceral Adipose Tissue and Cardiometabolic and Cardiovascular Disease Risk: The Framingham Heart Study
- (2021) Andreas A. Kammerlander et al. Journal of the American Heart Association
- Contemporary Medical Management of Peripheral Artery Disease
- (2021) Marc P. Bonaca et al. CIRCULATION RESEARCH
- Obesity-associated cardiovascular risk in women: hypertension and heart failure
- (2021) Jessica L. Faulkner CLINICAL SCIENCE
- Obesity Management in Cardiometabolic Disease: State of the Art
- (2021) Sean J. Iwamoto et al. Current Atherosclerosis Reports
- Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?
- (2021) Abhinav Sharma et al. CURRENT OPINION IN CARDIOLOGY
- Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies
- (2021) Min Seo Kim et al. EUROPEAN HEART JOURNAL
- Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018
- (2021) Li Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
- (2021) Emily Brown et al. LANCET
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of Bariatric Surgery Versus Non-Surgical Treatment on Blood Pressure: Systematic Review and Meta-Analysis
- (2021) Laicheng Wang et al. OBESITY SURGERY
- Digital Peripheral Arterial Tonometry and Cardiovascular Disease Events: The Framingham Heart Study
- (2021) Leroy L. Cooper et al. STROKE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
- (2021) Michael E. Nassif et al. NATURE MEDICINE
- SGLT inhibitors on weight and body mass: A meta‐analysis of 116 randomized‐controlled trials
- (2021) Alex Jia Yang Cheong et al. Obesity
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment
- (2021) Ashley J. Cooper et al. Current Obesity Reports
- Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018
- (2020) Chintan V. Dave et al. DIABETES CARE
- Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
- (2020) Valeria Raparelli et al. Journal of the American Heart Association
- Sex Differences in Blood Pressure Trajectories Over the Life Course
- (2020) Hongwei Ji et al. JAMA Cardiology
- Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association
- (2020) Mina K. Chung et al. CIRCULATION
- Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
- (2020) Laxmi S. Mehta et al. CIRCULATION
- Obesity, Hypertension, and Cardiac Dysfunction
- (2020) Alan J. Mouton et al. CIRCULATION RESEARCH
- Metabolic Inflammation and Insulin Resistance in Obesity
- (2020) Huaizhu Wu et al. CIRCULATION RESEARCH
- Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan
- (2020) Saori Sakaue et al. NATURE MEDICINE
- Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction
- (2020) Isabel T. N. Nguyen et al. PLoS One
- SELECT (Semaglutide effects on cardiovascular outcomes in people with overweight or obesity) rationale and design
- (2020) Donna H. Ryan et al. AMERICAN HEART JOURNAL
- Diabetes, Glycated Hemoglobin, and the Risk of Myocardial Infarction in Women and Men: A Prospective Cohort Study of the UK Biobank
- (2020) Marit de Jong et al. DIABETES CARE
- Age, Sex, and Depot‐Specific Differences in Adipose‐Tissue Estrogen Receptors in Individuals with Obesity
- (2020) Jay W. Porter et al. Obesity
- Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: A systematic review and dose-response meta-analysis of cohort studies among four million participants
- (2020) Jamal Rahmani et al. THROMBOSIS RESEARCH
- Trends in Obesity Prevalence by Race and Hispanic Origin—1999-2000 to 2017-2018
- (2020) Cynthia L. Ogden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Benefits and Risks of Bariatric Surgery in Adults
- (2020) David E. Arterburn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure
- (2020) Navin Suthahar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- (2020) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study
- (2020) Sanjoy K Paul et al. EUROPEAN HEART JOURNAL
- Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction
- (2020) Hidemi Sorimachi et al. EUROPEAN HEART JOURNAL
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options
- (2019) Caroline A. Andrew et al. EXPERT OPINION ON PHARMACOTHERAPY
- Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
- (2019) Bernard Zinman et al. Lancet Diabetes & Endocrinology
- Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity
- (2019) Maria J. Pereira et al. DRUGS
- Sex Differences in Cardiovascular Risk Profile From Childhood to Midlife Between Individuals Who Did and Did Not Develop Diabetes at Follow-up: The Bogalusa Heart Study
- (2019) Tingting Du et al. DIABETES CARE
- Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of MajorAdverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
- (2019) Thomas A. Zelniker et al. CIRCULATION
- Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta‐analysis of European, North American, and Australian cohorts
- (2019) S Santos et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood
- (2019) Amit V. Khera et al. CELL
- Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals
- (2019) Toshiaki Ohkuma et al. DIABETOLOGIA
- Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index
- (2019) Guo-Chong Chen et al. EUROPEAN HEART JOURNAL
- Progesterone Predisposes Females to Obesity-Associated Leptin-Mediated Endothelial Dysfunction via Upregulating Endothelial MR (Mineralocorticoid Receptor) Expression
- (2019) Jessica L. Faulkner et al. HYPERTENSION
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms by which GLP-1 receptor agonists and SGLT-2 inhibitors reduce cardiovascular risk
- (2019) Abhinav Sharma et al. Canadian Journal of Diabetes
- Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis
- (2019) Rajiv Mahajan et al. HEART
- Sex Differences in Circulating Biomarkers of Cardiovascular Disease
- (2019) Emily S. Lau et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
- (2019) Ildiko Lingvay et al. Lancet Diabetes & Endocrinology
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Sex Differences in Cardiometabolic Traits and Determinants of Exercise Capacity in Heart Failure With Preserved Ejection Fraction
- (2019) Emily S. Lau et al. JAMA Cardiology
- Body mass index and peripheral artery disease
- (2019) Sean P. Heffron et al. ATHEROSCLEROSIS
- Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy
- (2019) Michael C. Honigberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Assessing the Role of Health Behaviors, Socioeconomic Status, and Cumulative Stress for Racial/Ethnic Disparities in Obesity
- (2019) Adolfo G. Cuevas et al. Obesity
- Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease
- (2018) Margo B. Minissian et al. CIRCULATION
- Differences in Obesity Prevalence by Demographic Characteristics and Urbanization Level Among Adults in the United States, 2013-2016
- (2018) Craig M. Hales et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016
- (2018) Craig M. Hales et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population‐Based Tromsø Study
- (2018) Jocasta Ball et al. Journal of the American Heart Association
- Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
- (2018) Bernhard Ludvik et al. Lancet Diabetes & Endocrinology
- The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
- (2018) Nazir Savji et al. JACC-Heart Failure
- A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
- (2018) Maria J. Pereira et al. Diabetes Therapy
- A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
- (2018) Maria J. Pereira et al. Diabetes Therapy
- Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus
- (2018) Rosa Bretón‐Romero et al. Journal of the American Heart Association
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Body-Weight Fluctuations and Outcomes in Coronary Disease
- (2017) Sripal Bangalore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis
- (2017) Xiaoling Cai et al. Obesity
- Pregnancy-Related Mortality in the United States, 2011–2013
- (2017) Andreea A. Creanga et al. OBSTETRICS AND GYNECOLOGY
- Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis
- (2017) Chenhan Ma et al. BMJ-British Medical Journal
- Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis
- (2017) Chenhan Ma et al. BMJ-British Medical Journal
- Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease
- (2017) Kolsoum InanlooRahatloo et al. PLoS One
- Genetic Obesity and the Risk of Atrial FibrillationClinical Perspective
- (2016) Neal A. Chatterjee et al. CIRCULATION
- Reproductive Risk Factors and Coronary Heart Disease in the Women’s Health Initiative Observational StudyCLINICAL PERSPECTIVE
- (2016) Nisha I. Parikh et al. CIRCULATION
- Risk Factors for Incident Hospitalized Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal WomenClinical Perspective
- (2016) Charles B. Eaton et al. Circulation-Heart Failure
- The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift
- (2016) Filippo Crea et al. EUROPEAN HEART JOURNAL
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort
- (2016) Marc A. Rodger et al. THROMBOSIS RESEARCH
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus
- (2015) Judith G. Regensteiner et al. CIRCULATION
- Association of Cardiometabolic Multimorbidity With Mortality
- (2015) Emanuele Di Angelantonio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort
- (2015) Rajeev K. Pathak et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
- (2015) Renate B Schnabel et al. LANCET
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sex dimorphism and depot differences in adipose tissue function
- (2013) Ursula A. White et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation
- (2013) Hany S. Abed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Protein Kinase C-β Contributes to Impaired Endothelial Insulin Signaling in Humans With Diabetes Mellitus
- (2012) Corey E. Tabit et al. CIRCULATION
- Bariatric Surgery and Long-term Cardiovascular Events
- (2012) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endothelial Function Is Impaired across the Stages of the Menopause Transition in Healthy Women
- (2012) Kerrie L. Moreau et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Relation of Brachial and Digital Measures of Vascular Function in the Community
- (2011) Naomi M. Hamburg et al. HYPERTENSION
- Impact of Abdominal Visceral and Subcutaneous Adipose Tissue on Cardiometabolic Risk Factors: The Jackson Heart Study
- (2010) Jiankang Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation
- (2010) Usha B. Tedrow et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women
- (2009) John P. Forman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ante- and postnatal risk factors of venous thrombosis: a hospital-based case–control study
- (2008) A. F. JACOBSEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impact of Gender on the Myocardial Metabolic Response to Obesity
- (2008) Linda R. Peterson et al. JACC-Cardiovascular Imaging
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now